• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

114 例药物难治性特发性三叉神经痛行γ刀放射外科治疗的临床结果。

Clinical outcomes of 114 patients who underwent γ-knife radiosurgery for medically refractory idiopathic trigeminal neuralgia.

机构信息

Department of Neurosurgery, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041, Sichuan Province, China.

出版信息

J Clin Neurosci. 2012 Jan;19(1):71-4. doi: 10.1016/j.jocn.2011.03.020. Epub 2011 Dec 9.

DOI:10.1016/j.jocn.2011.03.020
PMID:22154202
Abstract

The optimal radiation dose and target of Gamma-knife radiosurgery (GKRS) for medically refractory idiopathic trigeminal neuralgia (TN) are contentious. We investigated the effects and trigeminal nerve deficits of GKRS using two isocenters to treat a great length of the trigeminal nerve. Between January 2005 and March 2010, 129 patients with idiopathic TN underwent GKRS at the West China Hospital of Sichuan University. A maximum central dose of 80-90 Gy was delivered to the trigeminal nerve root with two isocenters via a 4mm collimator helmet. One hundred and fourteen patients were followed-up periodically by telephone interview to determine the effects, trigeminal nerve deficits and time to the onset of pain relief. The mean follow-up duration was 29.6 months. One hundred and nine patients had complete or partial pain relief and the treatment failed in five patients. Nine patients experienced a recurrence after a mean time of 12.7 months, following an initial interval of pain relief. There were no significant differences between patients with different grades of pain relief with respect to central doses. The mean time to the onset of pain relief was 3.6 weeks. The time to the onset of complete pain relief was significantly shorter than that for partial pain relief. Forty-nine patients reported mild-to-moderate facial numbness and one patient experienced paroxysmal temporalis muscle spasms two weeks after the treatment. GKRS treatment for medically refractory idiopathic TN with two isocenters resulted in an initial pain improvement in 95.6% of patients. The early response to the treatment might suggest a good outcome but, given the high incidence of nerve deficits, GKRS for TN with two isocenters is not recommended as a routine treatment protocol.

摘要

伽玛刀放射外科治疗药物难治性特发性三叉神经痛(TN)的最佳辐射剂量和靶区存在争议。我们研究了使用两个等中心点治疗三叉神经根长节段的伽玛刀放射外科(GKRS)的效果和三叉神经损伤。2005 年 1 月至 2010 年 3 月,四川大学华西医院对 129 例特发性 TN 患者进行了 GKRS 治疗。通过 4mm 准直器头盔,以 80-90Gy 的最大中央剂量将神经根送达两个等中心点。114 例患者通过电话定期随访,以确定疗效、三叉神经损伤以及疼痛缓解的开始时间。平均随访时间为 29.6 个月。109 例患者完全或部分缓解疼痛,5 例治疗失败。9 例患者在初始缓解期后平均 12.7 个月出现复发。不同缓解程度的患者中央剂量无显著差异。疼痛缓解的平均时间为 3.6 周。完全缓解的时间明显短于部分缓解。49 例患者报告轻度至中度面部麻木,1 例患者在治疗后两周出现阵发性颞肌痉挛。对于药物难治性特发性 TN,使用两个等中心点的 GKRS 治疗,95.6%的患者初始疼痛改善。治疗的早期反应可能提示预后良好,但鉴于神经损伤的发生率较高,不建议将双等中心点 GKRS 作为 TN 的常规治疗方案。

相似文献

1
Clinical outcomes of 114 patients who underwent γ-knife radiosurgery for medically refractory idiopathic trigeminal neuralgia.114 例药物难治性特发性三叉神经痛行γ刀放射外科治疗的临床结果。
J Clin Neurosci. 2012 Jan;19(1):71-4. doi: 10.1016/j.jocn.2011.03.020. Epub 2011 Dec 9.
2
Repeat gamma knife radiosurgery for recurrent or refractory trigeminal neuralgia.复发性或难治性三叉神经痛的重复伽玛刀放射外科治疗。
Neurol India. 2008 Jan-Mar;56(1):36-41.
3
Gamma knife surgery for trigeminal neuralgia: outcome, imaging, and brainstem correlates.伽玛刀治疗三叉神经痛:疗效、影像学及脑干相关性
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):537-41. doi: 10.1016/j.ijrobp.2004.04.020.
4
Gamma knife radiosurgery for multiple sclerosis-related trigeminal neuralgia.伽玛刀放射外科治疗与多发性硬化相关的三叉神经痛。
Neurology. 2009 Oct 6;73(14):1149-54. doi: 10.1212/WNL.0b013e3181bacfb4.
5
The results of a third Gamma Knife procedure for recurrent trigeminal neuralgia.复发性三叉神经痛第三次伽玛刀治疗的结果。
J Neurosurg. 2015 Jan;122(1):169-79. doi: 10.3171/2014.9.JNS132779.
6
Outcomes of gamma knife radiosurgery for trigeminal neuralgia after a minimum 3-year follow-up.伽玛刀放射外科治疗三叉神经痛的 3 年以上随访结果。
J Clin Neurosci. 2011 May;18(5):645-8. doi: 10.1016/j.jocn.2010.09.007. Epub 2011 Mar 2.
7
Doses greater than 85 Gy and two isocenters in Gamma Knife surgery for trigeminal neuralgia: updated results.三叉神经痛伽玛刀手术中剂量大于85 Gy及双等中心:最新结果
J Neurosurg. 2006 Dec;105 Suppl:107-11. doi: 10.3171/sup.2006.105.7.107.
8
Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife radiosurgery.伽玛刀放射外科治疗三叉神经痛的疗效预测因素。
Neurosurgery. 2012 Mar;70(3):566-72; discussion 572-3. doi: 10.1227/NEU.0b013e3182320d36.
9
Gamma knife radiosurgery in patients with trigeminal neuralgia: quality of life, outcomes, and complications.三叉神经痛患者的伽玛刀放射外科治疗:生活质量、疗效及并发症
Clin Neurol Neurosurg. 2009 Feb;111(2):174-8. doi: 10.1016/j.clineuro.2008.09.020. Epub 2008 Nov 7.
10
Nonisocentric radiosurgical rhizotomy for trigeminal neuralgia.非等中心放射外科三叉神经切断术治疗三叉神经痛
Neurosurgery. 2009 Feb;64(2 Suppl):A84-90. doi: 10.1227/01.NEU.0000341631.49154.62.

引用本文的文献

1
Telemedicine in Surgical Care in Low- and Middle-Income Countries: A Scoping Review.中低收入国家外科护理中的远程医疗:范围综述。
World J Surg. 2022 Aug;46(8):1855-1869. doi: 10.1007/s00268-022-06549-2. Epub 2022 Apr 15.
2
Microvascular decompression as a second step treatment for trigeminal neuralgia in patients with failed two-isocentre gamma knife radiosurgery.微血管减压术作为两次等中心伽玛刀放射外科治疗失败的三叉神经痛患者的二线治疗。
Neurosurg Rev. 2022 Feb;45(1):783-791. doi: 10.1007/s10143-021-01587-1. Epub 2021 Jul 22.
3
Treatment Outcomes in Trigeminal Neuralgia-A Systematic Review of Domains, Dimensions and Measures.
三叉神经痛的治疗结果——对领域、维度和测量方法的系统评价
World Neurosurg X. 2020 Jan 27;6:100070. doi: 10.1016/j.wnsx.2020.100070. eCollection 2020 Apr.
4
Predictors of trigeminal nerve dysfunction following stereotactic radiosurgery for trigeminal neuralgia.三叉神经痛立体定向放射治疗后三叉神经功能障碍的预测因素
J Radiosurg SBRT. 2016;4(2):117-123.
5
Trigeminal Neuralgia.三叉神经痛
Asian J Neurosurg. 2017 Oct-Dec;12(4):585-597. doi: 10.4103/ajns.AJNS_67_14.